Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reports that women with hair loss had significantly lower levels of several biomarkers, including hemoglobin, iron, copper, selenium, vitamin D, vitamin B12, folate, and thyroid hormones, compared to healthy controls.

This study observed that among rheumatoid arthritis patients, 22% had thyroid dysfunction, with hypothyroidism as the most common, and weight gain and cold intolerance were significant predictors.

This study found that thyroid dysfunction was significantly more frequent in patients with alopecia areata compared to a control group, even when they lacked symptoms of thyroid issues, supporting the need for routine thyroid screening in this population.

This study found that METTL1 is upregulated in papillary thyroid cancer tissues and promotes cancer cell proliferation and metastasis through its tRNA methyltransferase activity.

This study aims to evaluate whether a subset of patients experience undetected hypothyroidism, termed the "famine response," during rapid weight loss after bariatric surgery, which may impact weight loss outcomes. Results are not reported in this abstract.

This chapter reviews management strategies for male pattern hair loss and provides treatment information for dermatology trainees, but it does not report new clinical results.

This article discusses the characteristics, diagnosis, and clinical presentation of different variants of lichen planopilaris on the scalp, with emphasis on cicatricial alopecia and the importance of clinical and trichoscopic monitoring; it presents no new clinical results.

In this study, researchers found that Hashimoto's thyroiditis patients, despite being in euthyroid status, experienced more severe extrathyroidal symptoms compared to healthy controls, and elevated thyroid antibodies were linked to lower health-related quality of life and increased inflammation.

This article reviews the influence of thyroid hormone on skin and hair health, emphasizing its role in epidermal homeostasis and hair growth, but reports no new experimental results.

This study reported that women with polycystic ovary syndrome had higher glypican-4 levels compared to controls, indicating its significant role in hormonal regulation associated with the condition.

This study found that a thyroid hormone receptor ẞ subtype-selective thyromimetic was effective in promoting hair growth in mouse and monkey models when applied topically.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

Some people with chronic hair loss may have thyroid autoimmunity.

This study suggests that vitamin D treatment may be less effective in reducing thyroid autoimmunity for euthyroid men with early-onset androgenic alopecia compared to other men with autoimmune thyroiditis.

This study found that thyroid volume was increased in PCOS patients with insulin resistance, with potential influences from TSH and LH levels on these changes.

This study found a strong association between thyroid disorders and dermatological conditions such as vitiligo, alopecia areata, and melasma, suggesting a benefit to including thyroid function tests in routine investigations for these conditions.

In this study, thyroid disorders were found to significantly affect physical and emotional well-being, with notable prevalence in married, urban, and non-working participants in South India.

This study found that patients with alopecia areata had significantly higher serum T3 and cortisol levels compared to healthy controls, although both remained within normal ranges, highlighting potential hormonal involvement in the condition. However, no significant differences were observed in T4 and TSH levels.

In this study, researchers found that cutaneous hyperpigmentation is a primary dermatological manifestation in patients with Graves' disease, with certain treatments like carbimazole and propranolol being statistically associated with skin symptoms.

In this study, researchers found varying levels of multiple autoantibody types among thyroid disorder patients, with 84.84% of those with immunological hypothyroidism reporting symptoms like weight gain and lethargy, whereas 81.81% of those with immune hyperthyroidism experienced hair loss.

This study found that serum IL-17A levels were significantly higher in patients with alopecia areata compared to healthy controls and correlated with disease severity and activity.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

This paper presents a case study of a 21-year-old male with thyroid hemiagenesis, where the left thyroid lobe and isthmus are absent, and discusses the anomaly's potential clinical consequences based on existing literature.

This study found an association between atopic dermatitis and autoimmune diseases in both adults and children, with women more likely to experience these complications, but further research is needed due to limited participant numbers.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

This report emphasizes the importance of considering thyroid tuberculosis in the differential diagnosis of cervical masses, highlighting the role of biopsy and histopathological examination for accurate diagnosis and treatment.

This study indicates that higher thyroid-stimulating hormone levels may be linked to post-COVID-19 hair loss in women, while ferritin levels showed no significant correlation.

In this study, polycystic ovarian disease was identified as a prevalent chronic endocrinopathy among women of reproductive age, with common dermatological symptoms such as hirsutism, acne, and androgenic alopecia.

This article discusses prevalent skin diseases in children, including alopecia areata, and reports no new clinical results; it outlines conditions and treatment options without presenting original data.

This review discusses the complexities of interpreting thyroid function tests, highlighting the challenges primary care providers face due to patient demand and misinformation, but reports no new results.